Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08XQA
|
|||
| Former ID |
DIB004287
|
|||
| Drug Name |
RSD-921
|
|||
| Synonyms |
PD 123497
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Anaesthesia [ICD-11: 9A78.6; ICD-9: 338] | Discontinued in Phase 2 | [1] | |
| Company |
University of British Columbia
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H28N2OS
|
|||
| Canonical SMILES |
CN(C1CCCCC1N2CCCC2)C(=O)CC3=C4C=CSC4=CC=C3
|
|||
| InChI |
1S/C21H28N2OS/c1-22(18-8-2-3-9-19(18)23-12-4-5-13-23)21(24)15-16-7-6-10-20-17(16)11-14-25-20/h6-7,10-11,14,18-19H,2-5,8-9,12-13,15H2,1H3/t18-,19-/m1/s1
|
|||
| InChIKey |
SYHJZCCNQDFHJQ-RTBURBONSA-N
|
|||
| CAS Number |
CAS 111728-01-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium channel unspecific (NaC) | Target Info | Modulator | [2] |
| KEGG Pathway | Dopaminergic synapse | |||
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006443) | |||
| REF 2 | Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921. Br J Pharmacol. 1999 May;127(1):9-18. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.